Bioavailability of Flavonoids: The Role of Cell Membrane Transporters

Polyphenols in Human Health and Disease

Volumn 1, Issue , 2014, Pages 489-511

  Ziberna, Lovro ^a   Fornasaro, Stefano ^a   Čvorović, Jovana ^a   Tramer, Federica ^a   Passamonti, Sabina ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Bioavailability; Flavonoids; Membrane transport; Polyphenols; Xenobiotic transporters

Indexed keywords

EID: 84902570798     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398456-2.00037-2     Document Type: Chapter

References (266)

1. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81(1):243S-255S.
2. Kishimoto Y., Tani M., Kondo K. Pleiotropic preventive effects of dietary polyphenols in cardiovascular diseases. Eur J Clin Nutr 2013, 67(5):532-535.
3. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002, 96(2-3):67-202.
4. Lipinski C., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001, 46(1-3):3-26.
5. Ho R.H., Kim R.B. Transporters and drug therapy: implications for drug disposition and disease. Clin Pharmacol Ther 2005, 78(3):260-277.
6. Dobson P.D., Kell D.B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat Rev Drug Discov 2008, 7(3):205-220.
7. Kell D.B., Dobson P.D., Oliver S.G. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. Drug Discov Today 2011, 16(15-16):704-714.
8. Saier M.H., Tran C.V., Barabote R.D. TCDB: the transporter classification database for membrane transport protein analyses and information. Nucleic Acids Res 2006, 34(Database issue):D181-86.
9. Li H., Benedito V.A., Udvardi M.K., Zhao P.X. TransportTP: a two-phase classification approach for membrane transporter prediction and characterization. BMC Bioinformatics 2009, 10:418.
10. Saier M.H., Yen M.R., Noto K., Tamang D.G., Elkan C. The transporter classification database: recent advances. Nucleic Acids Res 2009, 37:274-278. (Database issue).
11. Schinkel A.H., Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 2003, 55(1):3-29.
12. Szakacs G., Varadi A., Ozvegy-Laczka C., Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov Today 2008, 13(9-10):379-393.
13. Hediger M.A., Romero M.F., Peng J.B., Rolfs A., Takanaga H., Bruford E.A. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Introduction. Pflugers Arch 2004, 447(5):465-468.
14. Fredriksson R., Nordstrom K.J., Stephansson O., Hagglund M.G., Schioth H.B. The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett 2008, 582(27):3811-3816.
15. 3 exchange. J Biol Chem 1997, 272(42):26340-26345.
16. Li L., Lee T.K., Meier P.J., Ballatori N. Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J Biol Chem 1998, 273(26):16184-16191.
17. Mahagita C., Grassl S.M., Piyachaturawat P., Ballatori N. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport. Am J Physiol Gastrointest Liver Physiol 2007, 293(1):G271-278.
18. Ciarimboli G., Schlatter E. Regulation of organic cation transport. Pflugers Arch 2005, 449(5):423-441.
19. Srimaroeng C., Perry J.L., Physiology Pritchard J.B. structure, and regulation of the cloned organic anion transporters. Xenobiotica 2008, 38(7-8):889-935.
20. Passamonti S., Terdoslavich M., Franca R., Vanzo A., Tramer F., Braidot E., et al. Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab 2009, 10(4):369-394.
21. Ichiyanagi T., Shida Y., Rahman M.M., Hatano Y., Konishi T. Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats. J Agric Food Chem 2006, 54(18):6578-6587.
22. Bloedon L.T., Jeffcoat A.R., Lopaczynski W., Schell M.J., Black T.M., Dix K.J., et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. Am J Clin Nutr 2002, 76(5):1126-1137.
23. Ichiyanagi T., Shida Y., Rahman M.M., Hatano Y., Matsumoto H., Hirayama M., et al. Metabolic pathway of cyanidin 3-O-beta- d-glucopyranoside in rats. J Agric Food Chem 2005, 53(1):145-150.
24. Matsumoto H., Ichiyanagi T., Iida H., Ito K., Tsuda T., Hirayama M., et al. Ingested delphinidin-3-rutinoside is primarily excreted to urine as the intact form and to bile as the methylated form in rats. J Agric Food Chem 2006, 54(2):578-582.
25. Milbury P.E., Vita J.A., Blumberg J.B. Anthocyanins are bioavailable in humans following an acute dose of cranberry juice. J Nutr 2010, 140(6):1099-1104.
26. Kurilich A.C., Clevidence B.A., Britz S.J., Simon P.W., Novotny J.A. Plasma and urine responses are lower for acylated vs nonacylated anthocyanins from raw and cooked purple carrots. J Agric Food Chem 2005, 53(16):6537-6542.
27. Wu X., Pittman H.E., McKay S., Prior R.L. Aglycones and sugar moieties alter anthocyanin absorption and metabolism after berry consumption in weanling pigs. J Nutr 2005, 135(10):2417-2424.
28. Miyazawa T., Nakagawa K., Kudo M., Muraishi K., Someya K. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J Agric Food Chem 1999, 47(3):1083-1091.
29. Nielsen I.L., Dragsted L.O., Ravn-Haren G., Freese R., Rasmussen S.E. Absorption and excretion of black currant anthocyanins in humans and watanabe heritable hyperlipidemic rabbits. J Agric Food Chem 2003, 51(9):2813-2820.
30. Frank T., Janssen M., Netzet G., Christian B., Bitsch I., Netzel M. Absorption and excretion of elderberry (Sambucus nigra L.) anthocyanins in healthy humans. Methods Find Exp Clin Pharmacol 2007, 29(8):525-533.
31. Frank T., Netzel M., Strass G., Bitsch R., Bitsch I. Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juice. Can J Physiol Pharmacol 2003, 81(5):423-435.
32. Mertens-Talcott S.U., Rios J., Jilma-Stohlawetz P., Pacheco-Palencia L.A., Meibohm B., Talcott S.T., et al. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. J Agric Food Chem 2008, 56(17):7796-7802.
33. Reinboth M., Wolffram S., Abraham G., Ungemach F.R., Cermak R. Oral bioavailability of quercetin from different quercetin glycosides in dogs. Br J Nutr 2010, 104(2):198-203.
34. Zhao G., Zou L., Wang Z., Hu H., Hu Y., Peng L. Pharmacokinetic profile of total quercetin after single oral dose of tartary buckwheat extracts in rats. J Agric Food Chem 2011, 59(9):4435-4441.
35. Erlund I., Kosonen T., Alfthan G., Maenpaa J., Perttunen K., Kenraali J., et al. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol 2000, 56(8):545-553.
36. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 2001, 41(5):492-499.
37. Shimoi K., Yoshizumi K., Kido T., Usui Y., Yumoto T. Absorption and urinary excretion of quercetin, rutin, and alphaG-rutin, a water soluble flavonoid, in rats. J Agric Food Chem 2003, 51(9):2785-2789.
38. Lee J., Mitchell A.E. Pharmacokinetics of quercetin absorption from apples and onions in healthy humans. J Agric Food Chem 2012, 60(15):3874-3881.
39. Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000, 28(7):1056-1067.
40. Chen X., Yin O.Q., Zuo Z., Chow M.S. Pharmacokinetics and modeling of quercetin and metabolites. Pharm Res 2005, 22(6):892-901.
41. Schulz H.U., Schurer M., Bassler D., Weiser D. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Arzneimittelforschung 2005, 55(1):15-22.
42. Hollman P.C., Bijsman M.N., van Gameren Y., Cnossen E.P., de Vries J.H., Katan M.B. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res 1999, 31(6):569-573.
43. Li L., Jiang H., Wu H., Zeng S. Simultaneous determination of luteolin and apigenin in dog plasma by RP-HPLC. J Pharm Biomed Anal 2005, 37(3):615-620.
44. Chen T., Li L.P., Lu X.Y., Jiang H.D., Zeng S. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem 2007, 55(2):273-277.
45. Meyer H., Bolarinwa A., Wolfram G., Linseisen J. Bioavailability of apigenin from apiin-rich parsley in humans. Ann Nutr Metab 2006, 50(3):167-172.
46. Chen X., Cui L., Duan X., Ma B., Zhong D. Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metab Dispos 2006, 34(8):1345-1352.
47. Shimoi K., Okada H., Furugori M., Goda T., Takase S., Suzuki M., et al. Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett 1998, 438(3):220-224.
48. Wittemer S.M., Ploch M., Windeck T., Muller S.C., Drewelow B., Derendorf H., et al. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans. Phytomedicine 2005, 12(1-2):28-38.
49. Hao X., Cheng G., Sun J., Zou M., Yu J., Zhang S., et al. Validation of an HPLC method for the determination of scutellarin in rat plasma and its pharmacokinetics. J Pharm Biomed Anal 2005, 38(2):360-363.
50. Gradolatto A., Basly J.P., Berges R., Teyssier C., Chagnon M.C., Siess M.H., et al. Pharmacokinetics and metabolism of apigenin in female and male rats after a single oral administration. Drug Metab Dispos 2005, 33(1):49-54.
51. Xing J., Chen X., Zhong D. Absorption and enterohepatic circulation of baicalin in rats. Life Sci 2005, 78(2):140-146.
52. Mata-Bilbao Mde L., Andres-Lacueva C., Roura E., Jauregui O., Escribano E., Torre C., et al. Absorption and pharmacokinetics of grapefruit flavanones in beagles. Br J Nutr 2007, 98(1):86-92.
53. Erlund I., Meririnne E., Alfthan G., Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 2001, 131(2):235-241.
54. Manach C., Morand C., Gil-Izquierdo A., Bouteloup-Demange C., Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 2003, 57(2):235-242.
55. Kanaze F.I., Bounartzi M.I., Georgarakis M., Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007, 61(4):472-477.
56. Bugianesi R., Catasta G., Spigno P., D'Uva A., Maiani G. Naringenin from cooked tomato paste is bioavailable in men. J Nutr 2002, 132(11):3349-3352.
57. Takizawa Y., Morota T., Takeda S., Aburada M. Pharmacokinetics of (-)-epicatechin-3-O-gallate, an active component of Onpi-to, in rats. Biol Pharm Bull 2003, 26(5):608-612.
58. Henning S.M., Niu Y., Lee N.H., Thames G.D., Minutti R.R., Wang H., et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr 2004, 80(6):1558-1564.
59. Chow H.H., Hakim I.A., Vining D.R., Crowell J.A., Ranger-Moore J., Chew W.M., et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 2005, 11(12):4627-4633.
60. 3H]epigallocatechin gallate in rats after oral administration. J Agric Food Chem 2001, 49(8):4102-4112.
61. Chow H.H., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003, 9(9):3312-3319.
62. Chen L., Lee M.J., Li H., Yang C.S. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos 1997, 25(9):1045-1050.
63. Lee M.J., Lambert J.D., Prabhu S., Meng X., Lu H., Maliakal P., et al. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer Epidemiol Biomarkers Prev 2004, 13(1):132-137.
64. Kimura M., Umegaki K., Kasuya Y., Sugisawa A., Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 2002, 56(12):1186-1193.
65. 14C]Genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol Appl Pharmacol 2000, 164(2):206-215.
66. Piskula M.K. Soy isoflavone conjugation differs in fed and food-deprived rats. J Nutr 2000, 130(7):1766-1771.
67. Izumi T., Piskula M.K., Osawa S., Obata A., Tobe K., Saito M., et al. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000, 130(7):1695-1699.
68. Bell K.M., Pearce P.D., Ugarte C.E., Hendriks W.H. Preliminary investigation into the absorption of genistein and daidzein by domestic cats (Felis catus). J Nutr 2006, 136(Suppl. 7):2004-2006.
69. Shelnutt S.R., Cimino C.O., Wiggins P.A., Ronis M.J., Badger T.M. Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr 2002, 76(3):588-594.
70. Setchell K.D., Brown N.M., Desai P.B., Zimmer-Nechimias L., Wolfe B., Jakate A.S., et al. Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 2003, 133(4):1027-1035.
71. Cave N.J., Backus R.C., Marks S.L., Klasing K.C. The bioavailability and disposition kinetics of genistein in cats. J Vet Pharmacol Ther 2007, 30(4):327-335.
72. Tian X.J., Yang X.W., Yang X., Wang K. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. Int J Pharm 2009, 367(1-2):58-64.
73. Felgines C., Texier O., Besson C., Fraisse D., Lamaison J.L., Remesy C. Blackberry anthocyanins are slightly bioavailable in rats. J Nutr 2002, 132(6):1249-1253.
74. Talavera S., Felgines C., Texier O., Besson C., Lamaison J., Remesy C. Anthocyanins are efficiently absorbed from the stomach in anesthetized rats. J Nutr 2003, 133(12):4178-4182.
75. Novotny J.A., Clevidence B.A., Kurilich A.C. Anthocyanin kinetics are dependent on anthocyanin structure. Br J Nutr 2012, 107(4):504-509.
76. Piskula M.K., Yamakoshi J., Iwai Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett 1999, 447(2-3):287-291.
77. Crespy V., Morand C., Besson C., Manach C., Demigne C., Remesy C. Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. J Nutr 2001, 131(8):2109-2114.
78. Fernandes I., de Freitas V., Reis C., Mateus N. A new approach on the gastric absorption of anthocyanins. Food Funct 2012, 3(5):508-516.
79. Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic Biol Med 2000, 28(7):1056-1067.
80. Hong J., Lambert J.D., Lee S.H., Sinko P.J., Yang C.S. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 2003, 310(1):222-227.
81. Jodoin J., Demeule M., Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 2002, 1542(1-3):149-159.
82. Kalt W., Blumberg J.B., McDonald J.E., Vinqvist-Tymchuk M.R., Fillmore S.A., Graf B.A., et al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem 2008, 56(3):705-712.
83. El Mohsen M., Marks J., Kuhnle G., Moore K., Debnam E., Kaila Srai S., et al. Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats. Br J Nutr 2006, 95(1):51-58.
84. Passamonti S., Vrhovsek U., Vanzo A., Mattivi F. Fast access of some grape pigments to the brain. J Agric Food Chem 2005, 53(18):7029-7034.
85. Ishisaka A., Ichikawa S., Sakakibara H., Piskula M.K., Nakamura T., Kato Y., et al. Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radic Biol Med 2011, 51(7):1329-1336.
86. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998, 19(10):1771-1776.
87. Soucy N.V., Parkinson H.D., Sochaski M.A., Borghoff S.J. Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration. Toxicol Sci 2006, 90(1):230-240.
88. Doerge D.R., Twaddle N.C., Churchwell M.I., Newbold R.R., Delclos K.B. Lactational transfer of the soy isoflavone, genistein, in Sprague-Dawley rats consuming dietary genistein. Reprod Toxicol 2006, 21(3):307-312.
89. Chu K.O., Wang C.C., Chu C.Y., Choy K.W., Pang C.P., Rogers M.S. Uptake and distribution of catechins in fetal organs following in utero exposure in rats. Hum Reprod 2007, 22(1):280-287.
90. Borges G., Roowi S., Rouanet J.M., Duthie G.G., Lean M.E., Crozier A. The bioavailability of raspberry anthocyanins and ellagitannins in rats. Mol Nutr Food Res 2007, 51(6):714-725.
91. Ziberna L., Tramer F., Moze S., Vrhovsek U., Mattivi F., Passamonti S. Transport and bioactivity of cyanidin 3-glucoside into the vascular endothelium. Free Radic Biol Med 2012, 52(9):1750-1759.
92. Bornsek S.M., Ziberna L., Polak T., Vanzo A., Ulrih N.P., Abram V., et al. Bilberry and blueberry anthocyanins act as powerful intracellular antioxidants in mammalian cells. Food Chem 2012, 134(4):1878-1884.
93. Bellion P., Hofmann T., Pool-Zobel B.L., Will F., Dietrich H., Knaup B., et al. Antioxidant effectiveness of phenolic apple juice extracts and their gut fermentation products in the human colon carcinoma cell line Caco-2. J Agric Food Chem 2008, 56(15):6310-6317.
94. Jager W., Winter O., Halper B., Salamon A., Sartori M., Gajdzik L., et al. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat. Hepatology 1997, 26(6):1467-1476.
95. Ziberna L., Lunder M., Tramer F., Drevensek G., Passamonti S. The endothelial plasma membrane transporter bilitranslocase mediates rat aortic vasodilation induced by anthocyanins. Nutr Metab Cardiovasc Dis 2013, 23(1):68-74.
96. Ziberna L., Tramer F., Moze S., Vrhovsek U., Mattivi F., Passamonti S. Transport and bioactivity of cyanidin 3-glucoside into the vascular endothelium. Free Radic Biol Med 2012, 52(9):1750-1759.
97. Spencer J.P. The impact of fruit flavonoids on memory and cognition. Br J Nutr 2010, 104(Suppl. 3):40-47.
98. Krikorian R., Nash T.A., Shidler M.D., Shukitt-Hale B., Joseph J.A. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr 2010, 103(5):730-734.
99. Krikorian R., Boespflug E.L., Fleck D.E., Stein A.L., Wightman J.D., Shidler M.D., et al. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem 2012, 60(23):5736-5742.
100. Kalt W., Hanneken A., Milbury P., Tremblay F. Recent research on polyphenolics in vision and eye health. J Agric Food Chem 2010, 58(7):4001-4007.
101. Mattivi F, Vrhovsek U, Vanzo A, Passamonti S. Gastric absorption and distribution in liver, kidney and brain of grape anthocyanins. XXVIII World Congress of Vine and Wine Session IV, Wine and Health 4-9 July 2004; Wien, Austria; 2004.
102. Passamonti S., Vrhovsek U., Vanzo A., Mattivi F. The stomach as a site for anthocyanins absorption from food. FEBS Lett 2003, 544(1-3):210-213.
103. Brand W., Schutte M., Williamson G. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 2006, 60:508-519.
104. Mandery K., Balk B., Bujok K., Schmidt I., Fromm M., Glaeser H. Inhibition of hepatic uptake transporters by flavonoids. Eur J Pharm Sci 2012, 46(1-2):79-85.
105. Hong S.S., Seo K., Lim S.-C., Han H.-K. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol Res 2007, 56(6):468-4673.
106. Vanzo A., Terdoslavich M., Brandoni A., Torres A.M., Vrhovsek U., Passamonti S. Uptake of grape anthocyanins into the rat kidney and the involvement of bilitranslocase. Mol Nutr Food Res 2008, 52(10):1106-1116.
107. Uchida Y., Ohtsuki S., Katsukura Y., Ikeda C., Suzuki T., Kamiie J., et al. Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 2011, 117(2):333-345.
108. Wang X., Wolkoff A.W., Morris M.E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos 2005, 33(11):1666-1672.
109. Wang Q., Morris M.E. Flavonoids modulate monocarboxylate transporter-1-mediated transport of γ-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos 2007, 35(2):201-208.
110. Mandery K., Bujok K., Schmidt I., Keiser M., Siegmund W., Balk B., et al. Influence of the flavonoids apigenin, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1. Biochem Pharmacol 2010, 80(11):1746-1753.
111. An G., Morris M.E. Effects of single and multiple flavonoids on BCRP-mediated accumulation, cytotoxicity and transport of mitoxantrone in vitro. Pharm Res 2010, 27(7):1296-1308.
112. Lania-Pietrzak B., Michalak K., Hendrich A.B., Mosiadz D., Grynkiewicz G., Motohashi N., et al. Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids. Life Sci 2005, 77(15):1879-1891.
113. Song J., Kwon O., Chen S., Daruwala R., Eck P., Park J.B., et al. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and glucose. J Biol Chem 2002, 277(18):15252-15260.
114. Leslie E.M., Deeley R.G., Cole S.P. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001, 167(1):3-23.
115. Walle U.K., Galijatovic A., Walle T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem Pharmacol 1999, 58(3):431-438.
116. Zhang S., Yang X., Coburn R.A., Morris M.E. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem Pharmacol 2005, 70(4):627-639.
117. Ebert B., Seidel A., Lampen A. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate. Toxicol Sci 2007, 96(2):227-236.
118. van Zanden J.J., Wortelboer H.M., Bijlsma S., Punt A., Usta M., Bladeren P.J., et al. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 2005, 69(4):699-708.
119. Karawajczyk A., Drgan V., Medic N., Oboh G., Passamonti S., Novic M. Properties of flavonoids influencing the binding to bilitranslocase investigated by neural network modelling. Biochem Pharmacol 2007, 73(2):308-320.
120. Wang Y., Cao J., Zeng S. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J Pharm Pharmacol 2005, 57(6):751-758.
121. Shim C.K., Cheon E.P., Kang K.W., Seo K.S., Han H.K. Inhibition effect of flavonoids on monocarboxylate transporter 1 (MCT1) in Caco-2 cells. J Pharm Pharmacol 2007, 59(11):1515-1519.
122. Hong S.S., Seo K., Lim S.C., Han H. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3). Pharmacol Res 2007, 56(6):468-473.
123. Yu Z., Fong W.P., Cheng C.H. Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells. Drug Metab Dispos 2007, 35(6):981-986.
124. +-dependent l-ascorbic acid transporter SVCT2 expressed in brainstem cells, neurons, and neuroblastoma cells is inhibited by flavonoids. J Neurochem 2009, 108(3):563-577.
125. Leslie E.M., Mao Q., Oleschuk C.J., Deeley R.G., Cole S.P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol 2001, 59(5):1171-1180.
126. Mitsunaga Y., Takanaga H., Matsuo H., Naito M., Tsuruo T., Ohtani H., et al. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol 2000, 395(3):193-201.
127. Wu C.P., Calcagno A.M., Hladky S.B., Ambudkar S.V., Barrand M.A. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J 2005, 272(18):4725-4740.
128. Shirasaka Y., Kuraoka E., Spahn-Langguth H., Nakanishi T., Langguth P., Tamai I. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat. J Pharmacol Exp Ther 2010, 332(1):181-189.
129. Vaidyanathan J.B., Walle T. Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm Res 2001, 18(10):1420-1425.
130. Wang E.J., Barecki-Roach M., Johnson W.W. Elevation of P-glycoprotein function by a catechin in green tea. Biochem Biophys Res Commun 2002, 297(2):412-418.
131. Roth M., Timmermann B.N., Hagenbuch B. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 2011, 39(5):920-926.
132. Hong J., Lambert J., Lee S., Sinko P. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem Biophys Res Commun 2003, 310(1):222-227.
133. Versantvoort C.H., Broxterman H.J., Lankelma J., Feller N., Pinedo H.M. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem Pharmacol 1994, 48(6):1129-1136.
134. Walle U.K., French K.L., Walgren R.A., Walle T. Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. Res Commun Mol Pathol Pharmacol 1999, 103(1):45-56.
135. Imai Y., Tsukahara S., Asada S., Sugimoto Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res 2004, 64(12):4346-4352.
136. Enokizono J., Kusuhara H., Sugiyama Y. Effect of breast cancer resistance protein (Bcrp/Abcg2) on the disposition of phytoestrogens. Mol Pharmacol 2007, 72(4):967-975.
137. Castro A.F., Altenberg G.A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 1997, 53(1):89-93.
138. Biondi C., Pavan B., Dalpiaz A., Medici S., Lunghi L., Vesce F. Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. Mol Hum Reprod 2007, 13(1):77-83.
139. Dreiseitel A., Oosterhuis B., Vukman K.V., Schreier P., Oehme A., Locher S., et al. Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1. Br J Pharmacol 2009, 158(8):1942-1950.
140. Passamonti S., Vrhovsek U., Mattivi F. The interaction of anthocyanins with bilitranslocase. Biochem Biophys Res Commun 2002, 296(3):631-636.
141. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81(1):243S-255S.
142. Nait Chabane M., Al Ahmad A., Peluso J., Muller C.D., Ubeaud G. Quercetin and naringenin transport across human intestinal Caco-2 cells. J Pharm Pharmacol 2009, 61(11):1473-1483.
143. Walgren R.A., Lin J.-T., Kinne R.K.H., Walle T. Cellular uptake of dietary flavonoid quercetin 4'β-glucoside by sodium-dependent glucose transporter SGLT1. J Pharmacol Exp Ther 2000, 294(3):837-843.
144. +/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J Pharmacol Exp Ther 2007, 322(2):829-835.
145. Brand W., van der Wel P.A.I., Rein M.J., Barron D., Williamson G., van Bladeren P.J., et al. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos 2008, 36(9):1794-1802.
146. Brand W.W., Oosterhuis B.B., Krajcsi P.P., Barron D.D., Dionisi F.F., van Bladeren P.J.P., et al. Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells. Biopharm Drug Dispos 2011, 32(9):530-535.
147. Vaidyanathan J.B., Walle T. Cellular uptake and efflux of the tea flavonoid (-)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 2003, 307(2):745-752.
148. Iwanaga T., Takebe K., Kato I., Karaki S., Kuwahara A. Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. Biomed Res 2006, 27(5):243-254.
149. Faria A.A., Pestana D.D., Azevedo J.J., Martel F.F., de Freitas V.V., Azevedo I.I., et al. Absorption of anthocyanins through intestinal epithelial cells - Putative involvement of GLUT2. Mol Nutr Food Res 2009, 53(11):1430-1437.
150. Manzano S., Williamson G. Polyphenols and phenolic acids from strawberry and apple decrease glucose uptake and transport by human intestinal Caco-2 cells. Mol Nutr Food Res 2010, 54(12):1773-1780.
151. Passamonti S., Terdoslavich M., Franca R., Vanzo A., Tramer F., Braidot E., et al. Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab 2009, 10(4):369-394.
152. Nicolin V., Grill V., Micali F., Narducci P., Passamonti S. Immunolocalisation of bilitranslocase in mucosecretory and parietal cells of the rat gastric mucosa. J Mol Histol 2005, 36(1-2):45-50.
153. Cao J.J., Chen X.X., Liang J.J., Yu X.-Q.X., Xu A.-L.A., Chan E.E., et al. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra. Drug Metab Dispos 2007, 35(4):539-553.
154. Sesink A.L., Arts I.C., de Boer V.C., Breedveld P., Schellens J.H., Hollman P.C., et al. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 2005, 67(6):1999-2006.
155. Chen J., Wang S., Jia X., Bajimaya S., Lin H., Tam V.H., et al. Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition. Drug Metab Dispos 2005, 33(12):1777-1784.
156. Chen J., Lin H., Hu M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol Exp Ther 2003, 304(3):1228-1235.
157. Passamonti S., Vrhovsek U., Mattivi F. The interaction of anthocyanins with bilitranslocase. Biochem Biophys Res Commun 2002, 296(3):631-636.
158. Zuperl S., Fornasaro S., Novic M., Passamonti S. Experimental determination and prediction of bilitranslocase transport activity. Anal Chim Acta 2011, 705(1-2):322-333.
159. Terdoslavich M., de Graaf I.A., Proost J.H., Cocolo A., Passamonti S., Groothuis G.M. Bilitranslocase is involved in the uptake of bromosulfophthalein in rat and human liver. Drug Metab Lett 2013, 6(3):165-173.
160. Passamonti S., Terdoslavich M., Margon A., Cocolo A., Medic N., Micali F., et al. Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy. Function of bilitranslocase. FEBS J 2005, 272(21):5522-5535.
161. Passamonti S., Vanzo A., Vrhovsek U., Terdoslavich M., Cocolo A., Decorti G., et al. Hepatic uptake of grape anthocyanins and the role of bilitranslocase. Food Res Int 2005, 38:953-960.
162. Zhang Y., Hays A., Noblett A., Thapa M., Hua D.H., Hagenbuch B. Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives. J Nat Prod 2013, 76(3):368-373.
163. Zhang L., Li C., Lin G., Krajcsi P., Zuo Z. Hepatic metabolism and disposition of baicalein via the coupling of conjugation enzymes and transporters - In vitro and in vivo evidences. AAPS J 2011, 13(3):378-389.
164. van Zanden J.J., Wortelboer H.M., Bijlsma S., Punt A., Usta M., Bladeren PJv., et al. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem Pharmacol 2005, 69(4):699-708.
165. Xu H., Kulkarni K.H., Singh R., Yang Z., Wang S.W., Tam V.H., et al. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides. Mol Pharm 2009, 6(6):1703-1715.
166. Alvarez A., Real R., Perez M., Mendoza G., Prieto J., Merino G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci 2010, 99(2):598-617.
167. Miranda S.R., Lee J.K., Brouwer K.L., Wen Z., Smith P.C., Hawke R.L. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2). Drug Metab Dispos 2008, 36(11):2219-2226.
168. Tucker T.G., Milne A.M., Fournel-Gigleux S., Fenner K.S., Coughtrie M.W. Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum. Biochem Pharmacol 2012, 83(2):279-285.
169. Hilgendorf C., Ahlin G., Seithel A., Artursson P., Ungell A.L., Karlsson J. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 2007, 35(8):1333-1340.
170. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993, 62:385-427.
171. Kitagawa S., Nabekura T., Takahashi T., Nakamura Y., Sakamoto H., Tano H., et al. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 2005, 28(12):2274-2278.
172. Sheu M.-T., Liou Y.-B., Kao Y.-H., Lin Y.-K., Ho H.-O. A quantitative structure-activity relationship for the modulation effects of flavonoids on P-glycoprotein-mediated transport. Chem Pharm Bull (Tokyo) 2010, 58(9):1187-1194.
173. Zhang S., Sagawa K., Arnold R.D., Tseng E., Wang X., Morris M.E. Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo. J Pharm Sci 2010, 99(1):430-441.
174. Molnar J., Engi H., Hohmann J., Molnar P., Deli J., Wesolowska O., et al. Reversal of multidrug resitance by natural substances from plants. Curr Top Med Chem 2010, 10(17):1757-1768.
175. Choi Y.H., Chin Y.-W., Kim Y.G. Herb-drug interactions: Focus on metabolic enzymes and transporters. Arch Pharm Res 2011, 34(11):1843-1863.
176. Ali M.M., Agha F.G., El-Sammad N.M., Hassan S.K. Modulation of anticancer drug-induced P-glycoprotein expression by naringin. Z Naturforsch C 2009, 64(1-2):109-116.
177. Morris M., Zhang S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 2006, 78(18):2116-2130.
178. Zhang L., Lin G., Kovacs B., Jani M., Krajcsi P., Zuo Z. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur J Pharm Sci 2007, 31(3-4):221-231.
179. van Zanden J., van der Woude H., Vaessen J., Usta M., Wortelboer H., Cnubben N., et al. The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential. Biochem Pharmacol 2007, 74(2):345-351.
180. Felgines C., Talavera S., Texier O., Gil-Izquierdo A., Lamaison J.L., Remesy C. Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans. J Agric Food Chem 2005, 53(20):7721-7772.
181. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1):230S-242S.
182. Talavera S., Felgines C., Texier O., Besson C., Gil-Izquierdo A., Lamaison J.L., et al. Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 2005, 53(10):3902-3908.
183. Bourne L.C., Rice-Evans C.A. Detecting and measuring bioavailability of phenolics and flavonoids in humans: pharmacokinetics of urinary excretion of dietary ferulic acid. Methods Enzymol 1999, 299:91-106.
184. Choudhury R., Srai S.K., Debnam E., Rice-Evans C.A. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic Biol Med 1999, 27(3-4):278-286.
185. Graefe E.U., Veit M. Urinary metabolites of flavonoids and hydroxycinnamic acids in humans after application of a crude extract from Equisetum arvense. Phytomedicine 1999, 6(4):239-246.
186. Wright S.H., Dantzler W.H. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004, 84(3):987-1049.
187. Shitara Y., Horie T., Sugiyama Y. Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 2006, 27(5):425-446.
188. Wong C.C., Botting N.P., Orfila C., Al-Maharik N., Williamson G. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6). Biochem Pharmacol 2011, 81(7):942-949.
189. Williamson G., Aeberli I., Miguet L., Zhang Z., Sanchez M.B., Crespy V., et al. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab Dispos 2007, 35(8):1262-1268.
190. O'Leary K.A., Day A.J., Needs P.W., Mellon F.A., O'Brien N.M., Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human beta-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003, 65(3):479-491.
191. Hu Q.-H., Wang C., Li J.-M., Zhang D.-M., Kong L.-D. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009, 297(4):1080-1091.
192. Elias M.M., Lunazzi G.C., Passamonti S., Gazzin B., Miccio M., Stanta G., et al. Bilitranslocase localization and function in basolateral plasma membrane of renal proximal tubule in rat. Am J Physiol 1990, 259(4 Pt 2):559-564.
193. Vanzo A., Terdoslavich M., Brandoni A., Torres A.M., Vrhovsek U., Passamonti S. Uptake of grape anthocyanins into the rat kidney and the involvement of bilitranslocase. Mol Nutr Food Res 2008, 52(10):1106-1116.
194. Romiti N., Tramonti G., Donati A., Chieli E. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci 2004, 76(3):293-302.
195. Bansal T., Jaggi M., Khar R., Talegaonkar S. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. J Pharm Pharm Sci 2009, 12(1):46-78.
196. Konishi Y. Transepithelial transport of microbial metabolites of quercetin in intestinal Caco-2 cell monolayers. J Agric Food Chem 2005, 53(3):601-607.
197. Wang X., Wang Q., Morris M.E. Pharmacokinetic interaction between the flavonoid luteolin and γ-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters. AAPS J 2008, 10(1):47-55.
198. Kavvadias D., Sand P., Youdim K.A., Qaiser M.Z., Rice-Evans C., Baur R., et al. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol 2004, 142(5):811-820.
199. Kalt W.W., Blumberg J.B.J., McDonald J.E.J., Vinqvist-Tymchuk M.R.M., Fillmore S.A.E.S., Graf B.A.B., et al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem 2008, 56(3):705-712.
200. Milbury P.E., Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. J Agric Food Chem 2010, 58(7):3950-3956.
201. Yang H., Pang W., Lu H., Cheng D., Yan X., Cheng Y., et al. Comparison of metabolic profiling of cyanidin-3-O-galactoside and extracts from blueberry in aged mice. J Agric Food Chem 2011, 59(5):2069-2076.
202. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004, 16(1):1-13.
203. Decleves X., Jacob A., Yousif S., Shawahna R., Potin S., Scherrmann J.M. interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier. Curr Drug Metab 2011, 12(8):732-741.
204. Abbott N.J., Patabendige A.A.K., Dem Dolman, Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37(1):13-25.
205. Faria A., Pestana D., Teixeira D., Couraud P.O., Romero I., Weksler B., et al. Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct 2011, 2(1):39-44.
206. Gutmann H., Bruggisser R., Schaffner W., Bogman K., Botomino A., Drewe J. Transport of amentoflavone across the blood-brain barrier in vitro. Planta Med 2002, 68(9):804-807.
207. Youdim K., Qaiser M., Begley D., Rice-Evans C., Abbott N. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004, 36(5):592-604.
208. Youdim K., Dobbie M., Kuhnle G., Proteggente A., Abbott N., Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 2003, 85(1):180-192.
209. Yang Z., Sun X., Mei C., Sun X., Liu X., Chang Q. An in vitro transport model for rapid screening and predicting the permeability of candidate compounds at blood-brain barrier. J Asian Nat Prod Res 2011, 13(12):1087-1097.
210. Milbury P.E. Transport of flavonoids into the brain. Micronutrients and brain health 2009, 265. CRC. L. Packer, H. Sies, M. Eggersdorfer, E. Cadenas (Eds.).
211. Youdim K., Shukitt-Hale B., Joseph J. Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004, 37(11):1683-1693.
212. Shen S., Zhang W. ABC transporters and drug efflux at the blood-brain barrier. Rev Neurosci 2010, 21(1):29-53.
213. Hagenbuch B., Meier P.J. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003, 1609(1):1-18.
214. de Boer A.G., van der Sandt I.C., Gaillard P.J. The role of drug transporters at the blood-brain barrier. Annu Rev Pharmacol Toxicol 2003, 43:629-656.
215. Urquhart B.L., Kim R.B. Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol 2009, 65(11):1063-1070.
216. Aasmundstad T.A., Morland J., Paulsen R.E. Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. J Pharmacol Exp Ther 1995, 275(1):435-441.
217. Sattari M., Routledge P., Mashayekhi S. The influence of active transport systems on morphine-6-glucuronide transport in MDCKII and MDCK-PGP cells. Daru 2011, 19(6):412-416.
218. Bourasset F., Cisternino S., Temsamani J., Scherrmann J.M. Evidence for an active transport of morphine-6β-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier. J Neurochem 2003, 86(6):1564-1567.
219. Cornford E.M., Hyman S. Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx 2005, 2(1):27-43.
220. Bronger H., Konig J., Kopplow K., Steiner H.H., Ahmadi R., Herold-Mende C., et al. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res 2005, 65(24):11419-11428.
221. Tsuji A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2005, 2(1):54-62.
222. Lee G., Dallas S., Hong M., Bendayan R. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 2001, 53(4):569-596.
223. Cooray H.C., Blackmore C.G., Maskell L., Barrand M.A. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 2002, 13(16):2059-2063.
224. Zhang W., Mojsilovic-Petrovic J., Andrade M.F., Zhang H., Ball M., Stanimirovic D.B. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 2003, 17(14):2085-2087.
225. Wang C., Pimple S., Buolamwini J.K. Interaction of benzopyranone derivatives and related compounds with human concentrative nucleoside transporters 1, 2 and 3 heterologously expressed in porcine PK15 nucleoside transporter deficient cells. Structure-activity relationships and determinants of transporter affinity and selectivity. Biochem Pharmacol 2010, 79(3):307-320.
226. Maestro A., Terdoslavich M., Vanzo A., Kuku A., Tramer F., Nicolin V., et al. Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter. Cardiovasc Res 2010, 85(1):175-183.
227. Ziberna L., Tramer F., Moze S., Vrhovsek U., Mattivi F., Passamonti S. Transport and bioactivity of cyanidin 3-glucoside into the vascular endothelium. Free Radic Biol Med 2012, 52(9):1750-1759.
228. Vanzo A., Vrhovsek U., Tramer F., Mattivi F., Passamonti S. Exceptionally fast uptake and metabolism of cyanidin 3-glucoside by rat kidneys and liver. J Nat Prod 2011, 74(5):1049-1054.
229. Dufour C., Dangles O. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochim Biophys Acta 2005, 1721(1-3):164-173.
230. Kitson T.M. Spectrophotometric and kinetic studies on the binding of the bioflavonoid quercetin to bovine serum albumin. Biosci Biotechnol Biochem 2004, 68(10):2165-2170.
231. Ziberna L., Lunder M., Moze S., Vanzo A., Tramer F., Passamonti S., et al. Acute cardioprotective and cardiotoxic effects of bilberry anthocyanins in ischemia-reperfusion injury: beyond concentration-dependent antioxidant activity. Cardiovasc Toxicol 2010, 10(4):283-294.
232. Mennen L.I., Sapinho D., Ito H., Galan P., Hercberg S., Scalbert A. Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects - variability and possible use as biomarkers of polyphenol intake. Eur J Clin Nutr 2008, 62(4):519-525.
233. Terao J., Murota K., Kawai Y. Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo. Food Funct 2011, 2(1):11-17.
234. Kurin E., Atanasov A.G., Donath O., Heiss E.H., Dirsch V.M., Nagy M. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation. Planta Med 2012, 78(8):772-778.
235. Androutsopoulos V.P., Spandidos D.A. The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation. J Nutr Biochem 2013, 24(2):496-504.
236. Hayashi K., Iinuma M., Sasaki K., Hayashi T. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir. Arch Virol 2012, 157(8):1489-1498.
237. Calabrese V., Cornelius C., Dinkova-Kostova A.T., Iavicoli I., Di Paola R., Koverech A., et al. Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochimica Biophys Acta 2011, 1822(5):753-783.
238. Vargas A.J., Burd R. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutr Rev 2010, 68(7):418-428.
239. Son T.G., Camandola S., Mattson M.P. Hormetic dietary phytochemicals. Neuromolecular Med 2008, 10(4):236-246.
240. Nicholson S.K., Tucker G.A., Brameld J.M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc 2008, 67(1):42-47.
241. Mastaloudis A., Wood S.M. Age-related changes in cellular protection, purification, and inflammation-related gene expression: role of dietary phytonutrients. Ann NY Acad Sci 2012, 1259:112-120.
242. Wu C.C., Hsu M.C., Hsieh C.W., Lin J.B., Lai P.H., Wung B.S. Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 2006, 78(25):2889-2897.
243. Pirmohamed M. Drug-grapefruit juice interactions. BMJ 2013, 346:f1.
244. Alvarez A.I., Real R., Perez M., Mendoza G., Prieto J.G., Merino G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response. J Pharm Sci 2010, 99(2):598-617.
245. Dresser G.K., Bailey D.G., Leake B.F., Schwarz U.I., Dawson P.A., Freeman D.J., et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002, 71(1):11-20.
246. Cvetkovic M., Leake B., Fromm M.F., Wilkinson G.R., Kim R.B. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999, 27(8):866-871.
247. Bailey D.G., Dresser G.K., Leake B.F., Kim R.B. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther 2007, 81(4):495-502.
248. Kim K.A., Park P.W., Park J.Y. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers. Eur J Clin Pharmacol 2009, 65(6):609-614.
249. Choi J.S., Choi B.C., Choi K.E. Effect of quercetin on the pharmacokinetics of oral cyclosporine. Am J Health Syst Pharm 2004, 61(22):2406-2409.
250. Ducharme M.P., Warbasse L.H., Edwards D.J. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995, 57(5):485-491.
251. Rajnarayana K., Reddy M.S., Vidyasagar J., Krishna D.R. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole. Arzneimittelforschung 2004, 54(2):109-113.
252. Challa V.R., Ravindra Babu P., Challa S.R., Johnson B., Maheswari C. Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models. Drug Dev Ind Pharm 2013, 39(6):865-872.
253. Choi J.S., Han H.K. The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits. J Pharm Pharmacol 2004, 56(12):1537-1542.
254. Wang Y.H., Chao P.D., Hsiu S.L., Wen K.C., Hou Y.C. Lethal quercetin-digoxin interaction in pigs. Life Sci 2004, 74(10):1191-1197.
255. Choi J.S., Choi H.K., Shin S.C. Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats. Int J Pharm 2004, 275(1-2):165-170.
256. Dupuy J., Larrieu G., Sutra J.F., Lespine A., Alvinerie M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet Parasitol 2003, 112(4):337-347.
257. Choi J.S., Li X. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits. Int J Pharm 2005, 297(1-2):1-8.
258. Choi J.S., Shin S.C. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats. Int J Pharm 2005, 292(1-2):149-156.
259. Li X., Choi J.S. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 2007, 337(1-2):188-193.
260. Wang X., Morris M.E. Effects of the flavonoid chrysin on nitrofurantoin pharmacokinetics in rats: potential involvement of ABCG2. Drug Metab Dispos 2007, 35(2):268-274.
261. Yoshikawa M., Ikegami Y., Sano K., Yoshida H., Mitomo H., Sawada S., et al. Transport of SN-38 by the wild type of human ABC transporter ABCG2 and its inhibition by quercetin, a natural flavonoid. J Exp Ther Oncol 2004, 4(1):25-35.
262. Brand W., van der Wel P.A., Rein M.J., Barron D., Williamson G., van Bladeren P.J., et al. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos 2008, 36(9):1794-1802.
263. Zhao J., Dixon R.A. The 'ins' and 'outs' of flavonoid transport. Trends Plant Sci 2010, 15(2):72-80.
264. Kell D.B., Dobson P.D., Bilsland E., Oliver S.G. The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so. Drug Discov Today 2013, 18(5-6):218-239.
265. Dobson P.D., Kell D.B. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat Rev Drug Discov 2008, 7(3):205-220.
266. International Transporter C., Giacomini K.M., Huang S.M., Tweedie D.J., Benet L.Z., Brouwer K.L., et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010, 9(3):215-236.